Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5Stomach Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Surveys and Questionnaires 2Standard of Care 2Radiosurgery 2Practice Guidelines as Topic 2Oxaliplatin 2Nivolumab 2Leucovorin 2Fluorouracil 2tislelizumab 1irinotecan sucrosofate 1folfirinox 1fludarabine 1encorafenib 1durvalumab 1canakinumab 1avatrombopag 1aldesleukin 1Transurethral Resection of Prostate 1Sodium Chloride 1Restraint, Physical 1Remote Patient Monitoring 1Radiotherapy 1Psilocybin 1Poly(ADP-ribose) Polymerase Inhibitors 1Panitumumab 1Observation 1Massage 1Magnetic Resonance Spectroscopy 1Levoleucovorin 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Gastrointestinal Neoplasms × irinotecan sucrosofate × Clear all
NCT04005339 2026-01-26

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

Georgetown University

Phase 2 Active not recruiting
48 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡